Dr. LupaΘcu has consistently contributed to the field of pharmaceutical sciences through original, high-impact research. Her publications include 37 full articles, 24 in ISI journals, and multiple authored books π. She has led a key project on pioglitazone-curcumin-loaded chitosan nanoparticles, a novel drug delivery system targeting Type 2 diabetes mellitus β an area of urgent global healthcare need π. Her H-index (up to 11) and over 500 citations across platforms demonstrate significant scholarly influence π.
π Education & ExperienceΒ
π Education:
-
π§ͺ Bachelor of Pharmacy, UMF “Grigore T. Popa” IaΘi (2004β2009)
-
𧬠PhD in Pharmaceutical Chemistry, UMF “Grigore T. Popa” IaΘi (2009β2013)
-
π Residency in Pharmaceutical Laboratory (2015β2019)
-
πΌ Residency in General Pharmacy (2020β2023)
π§βπ« Experience:
-
π©βπ« Assistant, UMF IaΘi β Faculty of Pharmacy (2013β2016)
-
π©βπ¬ Lecturer, Pharmaceutical Chemistry (2016βpresent)
-
π Scientific Coordinator β 40 graduation theses
-
π₯ Guidance Committee β 3 PhD students
-
π Specializations abroad:
Professional Development ππ
Dr. LupaΘcu is actively involved in enhancing her scientific and academic profile through international research networks π, professional societies, and specialized workshops π§βπ¬. She is a steering committee member in the COST Action CA19140 β Focused Ion Technology for Nanomaterials βοΈ and contributes to the advancement of pharmaceutical chemistry via roles in scientific societies and editorial boards π. Her participation in national and international conferences, editorial projects (e.g., Polymers, Pharmaceutics journals) βοΈ, and training programs such as drug administration techniques in animal models π highlights her dynamic engagement with cutting-edge pharmaceutical research and innovation π‘.
Research Focus ππ€
Dr. LupaΘcuβs research centers around innovative drug delivery systems, particularly those targeting type 2 diabetes mellitus therapy using biopolymer-based nanoparticles like chitosan ππΏ. She has explored the synergy between active pharmaceutical ingredients such as pioglitazone and curcumin, embedded within polymer matrices to enhance therapeutic effects π. Her interest lies in optimizing the pharmacological profile of oral antidiabetic agents via nanotechnological approaches π§«. Active in interdisciplinary and translational research, she merges pharmaceutical chemistry, materials science, and nanomedicine π§ͺπ. Her work contributes to developing smarter, safer, and more effective drug systems for chronic diseases π‘οΈ.
Awards and Honors πποΈ
-
π Best Paper Award β International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2022)
-
π₯ Best Oral Presentation β International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2021)
-
ποΈ Originality of Results Award β Romanian National Pharmacy Congress, 16th Edition (October 2016)
Publications & Citations π
-
π An overview of biopolymeric electrospun nanofibers based on polysaccharides for wound healing management π
2020 π Cited by 160
-
π Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers π
2021 π Cited by 94
-
π The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety π
2013 π Cited by 40
-
π New theophylline derivatives with potential pharmacological activity π
2010 π Cited by 34
-
π Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold π
2017 π Cited by 29
-
π Development and characterization of novel films based on sulfonamide-chitosan derivatives for potential wound dressing π
2015 π Cited by 28
-
π New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile π
2021 π Cited by 18
-
π The influence of a new rutin derivative on homocysteine, cholesterol and total antioxidative status in experimental diabetes in rat π
2013 π Cited by 17
-
π The influence of a new rutin derivative in an experimental model of induced hyperhomocysteinemia in rats π
2017 π Cited by 16
-
π Synthesis and biological evaluation of some new rutin semisynthetic derivatives as antibacterial agents π
2012 π Cited by 11
-
π New derivatives of aryl-propionic acid. Synthesis and biological evaluation π
2013 π Cited by 6
-
π New hydrazones with pyrazolone structure: synthesis, characterization and biological evaluation π
2013 π Cited by 6
π Conclusion:
Given her pioneering work in nanomedicine, consistent scientific productivity, and prior accolades, Dr. Florentina LupaΘcu exemplifies the qualities of a Best Paper Award recipient. Her research offers both academic value and real-world therapeutic potential, making her a standout candidate for further recognition π₯.